About Qualicaps
Qualicaps is a company based in Whitsett (United States) founded in 1965 was acquired by Roquette in July 2023. Qualicaps offers products and services including Hard Two-Piece Capsules, Equipment, and Services. Qualicaps operates in a competitive market with competitors including Akums, Jubilant Life Sciences, Unither, Recipharm and Nectar Lifesciences, among others.
- Headquarter Whitsett, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Qualicaps, Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Qualicaps
Qualicaps offers a comprehensive portfolio of products and services, including Hard Two-Piece Capsules, Equipment, and Services.
Capsules used for drug delivery in pharmaceutical applications
Machinery designed for capsule production processes
Expert services for scientific and engineering needs
People of Qualicaps
Unlock access to complete
Funding Insights of Qualicaps
Detailed funding history for Qualicaps
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Qualicaps
Qualicaps has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Roquette and Mitsubishi Chemical Group Corporation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Manufactures high-quality chemical products for various industrial applications.
|
Locked | Locked | Locked | |
|
Plant-based pharma, nutraceuticals, and cosmetics are manufactured as a CDMO.
|
Locked | Locked | Locked |
Investor details for Qualicaps
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Qualicaps
Investment portfolio details for Qualicaps
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Qualicaps
Detailed financials for Qualicaps
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Qualicaps Comparisons
Peer comparison for Qualicaps
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Qualicaps
Qualicaps operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Akums, Jubilant Life Sciences, Unither, Recipharm and Nectar Lifesciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
CDMO focusing on spectrum of dosage forms and therapeutic segments
|
|
| Locked | Locked | Locked |
Company offering a suite of R&D and manufacturing services for small molecules and generics
|
|
| Locked | Locked | Locked |
Contract development and manufacturing organization for proprietary and generic drugs
|
|
| Locked | Locked | Locked |
Pharmaceutical development and manufacturing services are offered contractually.
|
|
| Locked | Locked | Locked |
Cephalosporin APIs and generic formulations are manufactured.
|
|
| Locked | Locked | Locked |
CDMO with a focus on early phase drug product development
|
Detailed competitors of Qualicaps
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Qualicaps
Complete news archive for Qualicaps
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Qualicaps
Qualicaps was founded in 1965.
Qualicaps is headquartered in Whitsett, United States. It is registered at Whitsett, North Carolina, United States.
Founded in 1965, Qualicaps operates in the pharmaceutical sector from its base in Whitsett, United States, as a subsidiary of Mitsubishi Chemical Holdings Corporation. Two-piece hard capsules in gelatin and hypromellose variants are produced for solids, liquids, and inhalation uses. Equipment such as capsule filling, band-sealing, inspection, and imprinting machines is supplied to support solid oral dosage production globally. The company was previously known as Shionogi Qualicaps.
Qualicaps's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
Qualicaps offers Hard Two-Piece Capsules, Equipment, and Services.
Qualicaps has 2 investors. Key investors include Roquette, and Mitsubishi Chemical Group Corporation.